These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 11907995)
1. Drug-related morbidity and mortality: an economic and clinical perspective. Bootman JL Manag Care; 2002 Feb; 11(2 Suppl):12-5. PubMed ID: 11907995 [No Abstract] [Full Text] [Related]
2. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows. Levenson D Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947 [No Abstract] [Full Text] [Related]
3. The economic value of individualizing drug therapy. Navarro RP Manag Care Interface; 1997 Oct; 10(10):96-8. PubMed ID: 10174423 [No Abstract] [Full Text] [Related]
4. The pharmacoeconomics of high-cost biotechnology products. Dana WJ; Farthing K Pharm Pract Manag Q; 1998 Jul; 18(2):23-31. PubMed ID: 10185236 [TBL] [Abstract][Full Text] [Related]
5. Patient compliance: changing patterns of disease and health care costs. Cluff LE Hosp Formul; 1985 Apr; 20(4):503-4, 507, 510. PubMed ID: 10311084 [TBL] [Abstract][Full Text] [Related]
6. Expenditures for prescription drugs: too much or not enough? Schumock GT; Walton SM Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578 [TBL] [Abstract][Full Text] [Related]
7. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Piette JD; Heisler M; Horne R; Caleb Alexander G Soc Sci Med; 2006 Feb; 62(4):846-57. PubMed ID: 16095789 [TBL] [Abstract][Full Text] [Related]
8. Special report: the value of pharmaceuticals. An "expensive" drug may be the most cost effective. Siegelman S Bus Health; 1991; [VALUE]():8-14. PubMed ID: 10170908 [TBL] [Abstract][Full Text] [Related]
9. Differences in medical expenditure according to drug prices. Ueshima H Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148 [No Abstract] [Full Text] [Related]
10. Chronic conditions and disabilities: trends and issues for private drug plans. Boccuti C; Moon M; Dowling K Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797 [No Abstract] [Full Text] [Related]
11. The growth of prescription drug costs and national health expenditures. Cole DL Med Interface; 1995 Mar; 8(3):42-3. PubMed ID: 10141387 [No Abstract] [Full Text] [Related]
12. Retiree health care: a new model for improving health and reducing costs. Erwin WG; Angaran DM Empl Benefits J; 1997 Jun; 22(2):2-4. PubMed ID: 10168419 [TBL] [Abstract][Full Text] [Related]
13. How pharmaceuticals cut direct & indirect costs of therapy. Levy RA Pharm Times; 1985 Dec; 51(12):82-8. PubMed ID: 10311420 [No Abstract] [Full Text] [Related]
14. Metabolic agents lead in total dollars spent. Sipkoff M Manag Care; 2009 Mar; 18(3):11-2. PubMed ID: 19405359 [No Abstract] [Full Text] [Related]
15. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311 [TBL] [Abstract][Full Text] [Related]
16. Trends in prescription drug expenditures by Medicaid enrollees. Banthin JS; Miller GE Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061 [TBL] [Abstract][Full Text] [Related]
17. Perspective. Senior drug use unique, needs management, analysts say. Med Health; 2001 Aug; 55(30):7-8. PubMed ID: 11507947 [No Abstract] [Full Text] [Related]
18. Datawatch: Update on Rx drug spending. Bus Health; 2001 Sep; 19(8):48. PubMed ID: 11665673 [No Abstract] [Full Text] [Related]
19. Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population. Ouyang L; Grosse SD; Kenneson A J Child Neurol; 2008 Aug; 23(8):883-8. PubMed ID: 18403582 [TBL] [Abstract][Full Text] [Related]
20. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services. Hennessy KD; Green-Hennessy S; Buck JA; Miller K J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096 [No Abstract] [Full Text] [Related] [Next] [New Search]